ScottiV., MeattiniI., FranzeseC.. Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survival. Tumori.2014; 100(3): 289–295.
2.
ArriagadaR., Le ChevalierT., RivièreA.. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol.2002; 13(5): 748–754.
3.
AupérinA., ArriagadaR., PignonJ.P.. Prophylactic Cranial Irradiation Overview Collaborative Group. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med.1999; 341(7): 476–484.
4.
CrivellariG., MonfardiniS., StragliottoS., MarinoD., AversaS.M.Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses. Oncologist.2007; 12(1): 79–89.
5.
LallyB.E., UrbanicJ.J., BlackstockA.W., MillerA.A., PerryM.C.Small cell lung cancer: have we made any progress over the last 25 years?Oncologist.2007; 12(9): 1096–1104.
6.
BerendsenH.H., de LeijL., PostmusP.E., Ter HaarJ.G., PoppemaS., TheT.H.Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen. J Clin Pathol.1988; 41(3): 273–276.
7.
TrilletV., RevelD., CombaretV.. Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies. Br J Cancer.1989; 60(1): 83–88.
8.
SpechtL., YahalomJ., IllidgeT.. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys.2014; 89(1): 49–58.
